Episodes (Page 2)
✨
Emily Conley discusses small molecules for a rare kidney disease.
Emily Conley
✨
Neil Kumar discusses building BridgeBio Pharma for rare diseases.
✨
Marc Tessier-Lavigne on Xaira Therapeutics' AI-driven drug discovery.
✨
Art Krieg on Zola Therapeutics' cancer treatments.
Art Krieg
✨
Eric Fischer discusses targeted protein degraders.
Eric Fischer
✨
Bruce Levine and Mags McCarthy on their science song.
✨
Dr. Lachelle Weeks on predicting leukemia risk.
Lachelle Weeks
✨
Jen Adair on affordable gene and cell therapies.
Jen Adair
✨
Sabah Oney on CAR-T cells for solid tumors.
Sabah Oney
✨
Andy Rachleff and Yung Lie on supporting science.
Andy Rachleff
✨
Claire Mazumdar on Bicara Therapeutics' approach.
Claire Mazumdar
✨
John Rinn on long non-coding RNA discoveries.
✨
Ethan Weiss and Josh Lehrer on Marea Therapeutics.
Ethan Weiss
✨
Peyton Greenside on ML-guided biologics discovery.
✨
Kevin Parker on Cartography Biosciences' work.
✨
David Roblin on building Relation Therapeutics.
✨
Andy Scharenberg on Umoja Biopharma's innovation.
Andy Scharenberg
✨
Najat Khan on Recursion's tech-driven approach.
Najat Khan
✨
Robert Blum on Cytokinetics' biopharma model.
✨
Mostafa Ronaghi on Cellanome's technology.